Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prendergast

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
The European Journal of Neuroscience|November 22, 2011
Altered apoptotic responses in neurons lacking RhoB GTPaseSara Barberan, Kara McNair, Khalil Iqbal, et al.
Plos One|March 4, 2014
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetesArturo Bravo-Nuevo, Alice Marcy, Minzhou Huang, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenaseSanjeev Kumar, Daniel Jaller, Bhumika Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2021
The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic MechanismLauren M F Merlo, Weidan Peng, James B DuHadaway, et al.
Genomics|February 26, 1999
The murine Bin1 gene functions early in myogenesis and defines a new region of synteny between mouse chromosome 18 and human chromosome 2N C Mao, E Steingrimsson, J DuHadaway, et al.
Cancer Research|August 19, 2007
Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancerMee Young Chang, Janette Boulden, Jessica B Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological featuresTatsuro Tajiri, Xueyuan Liu, Patricia M Thompson, et al.
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Oncogene|June 25, 1999
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanismsK Elliott, D Sakamuro, A Basu, et al.
Clinical Immunology (Orlando, Fla.)|February 23, 2017
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritisLauren M F Merlo, Samantha Grabler, James B DuHadaway, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
The European Journal of Neuroscience|November 22, 2011
Altered apoptotic responses in neurons lacking RhoB GTPaseSara Barberan, Kara McNair, Khalil Iqbal, et al.
Plos One|March 4, 2014
Meglumine exerts protective effects against features of metabolic syndrome and type II diabetesArturo Bravo-Nuevo, Alice Marcy, Minzhou Huang, et al.
Journal of Medicinal Chemistry|July 31, 2008
Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenaseSanjeev Kumar, Daniel Jaller, Bhumika Patel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2021
The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic MechanismLauren M F Merlo, Weidan Peng, James B DuHadaway, et al.
Genomics|February 26, 1999
The murine Bin1 gene functions early in myogenesis and defines a new region of synteny between mouse chromosome 18 and human chromosome 2N C Mao, E Steingrimsson, J DuHadaway, et al.
Cancer Research|August 19, 2007
Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancerMee Young Chang, Janette Boulden, Jessica B Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological featuresTatsuro Tajiri, Xueyuan Liu, Patricia M Thompson, et al.
Oncoimmunology|December 25, 2012
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophanRichard Metz, Sonja Rust, James B Duhadaway, et al.
Oncogene|June 25, 1999
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanismsK Elliott, D Sakamuro, A Basu, et al.
Clinical Immunology (Orlando, Fla.)|February 23, 2017
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritisLauren M F Merlo, Samantha Grabler, James B DuHadaway, et al.
Pageof 23